225Ac–DOTATATE actinium-225 neuroendocrine tumors radiobiology radiolabeling radionuclide production radiopharmaceuticals targeted alpha-therapy targeted radionuclide therapy

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
24 Mar 2023
Historique:
received: 14 02 2023
revised: 18 03 2023
accepted: 22 03 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of

Identifiants

pubmed: 37111537
pii: pharmaceutics15041051
doi: 10.3390/pharmaceutics15041051
pmc: PMC10146019
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Mol Pharm. 2018 Apr 2;15(4):1457-1466
pubmed: 29502411
Pharmaceuticals (Basel). 2021 Jul 06;14(7):
pubmed: 34358076
J Nucl Med. 2004 Jan;45(1):129-37
pubmed: 14734685
Nucl Med Biol. 2022 Sep-Oct;112-113:35-43
pubmed: 35797877
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1336-1344
pubmed: 30566620
Lancet Reg Health Eur. 2022 Sep 23;23:100510
pubmed: 36176500
Clin Nucl Med. 2017 Jun;42(6):436-443
pubmed: 28263217
Cancer Biother Radiopharm. 2022 Jun;37(5):355-363
pubmed: 35695807
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):205-10
pubmed: 24030668
Theranostics. 2016 Mar 01;6(5):698-709
pubmed: 27022417
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1040-6
pubmed: 26611427
Anticancer Res. 2004 Jan-Feb;24(1):101-5
pubmed: 15015582
Dev Neurobiol. 2012 Sep;72(9):1181-95
pubmed: 21976424
J Nucl Med. 2005 Jan;46 Suppl 1:99S-106S
pubmed: 15653658
J Clin Oncol. 2018 Sep 1;36(25):2578-2584
pubmed: 29878866
N Engl J Med. 2013 Jul 18;369(3):213-23
pubmed: 23863050
EJNMMI Phys. 2021 Aug 18;8(1):60
pubmed: 34406515
J Nucl Med. 2011 Jul;52(7):1041-7
pubmed: 21680680
Digestion. 1996;57 Suppl 1:57-61
pubmed: 8813472
J Nucl Med. 2011 Sep;52(9):1361-8
pubmed: 21795361
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2106-19
pubmed: 25070685
Bioconjug Chem. 2021 Jul 21;32(7):1348-1363
pubmed: 32216377
J Clin Oncol. 2008 Jun 20;26(18):3063-72
pubmed: 18565894
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3408-3421
pubmed: 33772332
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2212-2217.e1
pubmed: 30580091
Curr Radiopharm. 2018;11(3):200-208
pubmed: 29732998
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):934-946
pubmed: 31707430
Nucl Med Biol. 2007 Feb;34(2):185-93
pubmed: 17307126
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1595-1606
pubmed: 34837103
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):490-499
pubmed: 27704193
Pharmaceuticals (Basel). 2014 Mar 13;7(3):353-65
pubmed: 24633429
Phys Med Biol. 2021 Jan 29;66(3):035016
pubmed: 33321484
PLoS One. 2013 Apr 22;8(4):e62487
pubmed: 23614051
J Clin Oncol. 2010 Apr 1;28(10):1652-9
pubmed: 20194865
Nucl Med Rev Cent East Eur. 2016;19(2):111-7
pubmed: 27479788
J Clin Oncol. 2008 May 1;26(13):2124-30
pubmed: 18445841
Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14712-14717
pubmed: 28963750
Cancer Discov. 2018 Apr;8(4):OF2
pubmed: 29487054
Bioconjug Chem. 2022 Dec 21;33(12):2381-2397
pubmed: 36378809
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):871-880
pubmed: 34537893
J Clin Oncol. 2011 Jun 10;29(17):2416-23
pubmed: 21555692
Eur J Nucl Med Mol Imaging. 2007 Feb;34(2):219-27
pubmed: 17021812
Br J Radiol. 2018 Nov;91(1091):20180041
pubmed: 29513039
Eur J Nucl Med. 2000 Mar;27(3):273-82
pubmed: 10774879
Pol Arch Intern Med. 2022 Aug 22;132(7-8):
pubmed: 35699734
J Chromatogr A. 2015 Feb 6;1380:55-63
pubmed: 25596759
Cancer Biother Radiopharm. 2000 Jun;15(3):235-44
pubmed: 10941530
Clin Cancer Res. 2008 Jun 1;14(11):3555-61
pubmed: 18519789
Ann N Y Acad Sci. 1994 Sep 15;733:496-506
pubmed: 7978900
Life Sci. 1982 Sep 13;31(11):1133-40
pubmed: 6128648
Q J Nucl Med Mol Imaging. 2020 Sep;64(3):265-277
pubmed: 32441067
Bioconjug Chem. 2022 Oct 19;33(10):1900-1921
pubmed: 36126334
Front Med (Lausanne). 2022 Dec 07;9:1034315
pubmed: 36569154
Chem Biol Drug Des. 2018 Jul;92(1):1344-1356
pubmed: 29611298
Sci Rep. 2017 Aug 15;7(1):8216
pubmed: 28811573
Oncoimmunology. 2019 May 1;8(8):1607673
pubmed: 31413916
Mol Pharm. 2019 Dec 2;16(12):4807-4816
pubmed: 31518138
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2125-35
pubmed: 21892623
Front Med (Lausanne). 2015 Mar 17;2:12
pubmed: 25853132
Appl Radiat Isot. 2002 Dec;57(6):841-7
pubmed: 12406626
Appl Radiat Isot. 2005 Mar;62(3):383-7
pubmed: 15607913
Pharmaceutics. 2021 Jun 18;13(6):
pubmed: 34207408
Nucl Med Biol. 2022 Jul-Aug;110-111:28-36
pubmed: 35512517
Neuroendocrinology. 2019;108(3):256-264
pubmed: 30352433
Molecules. 2019 Sep 19;24(18):
pubmed: 31546752
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):152-160
pubmed: 32472437
Ann N Y Acad Sci. 2004 Apr;1014:234-45
pubmed: 15153440
Appl Radiat Isot. 2018 Oct;140:18-23
pubmed: 29936271
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):897-903
pubmed: 16467104
Cancer Res. 2005 Jun 1;65(11):4888-95
pubmed: 15930310
J Nucl Med. 2020 Apr;61(4):563-569
pubmed: 31586001
J Nucl Med. 2020 Jan;61(1):62-69
pubmed: 31101746
Pharmaceuticals (Basel). 2022 Sep 21;15(10):
pubmed: 36297279
EJNMMI Radiopharm Chem. 2022 Oct 23;7(1):28
pubmed: 36274098
Pharmacol Ther. 2015 Aug;152:98-110
pubmed: 25956467
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1141-57
pubmed: 24668274
Pharmaceutics. 2021 May 13;13(5):
pubmed: 34068206
Endocrinol Metab Clin North Am. 2018 Sep;47(3):615-625
pubmed: 30098719
Front Oncol. 2022 Nov 24;12:993182
pubmed: 36505778
Front Oncol. 2020 Nov 05;10:531660
pubmed: 33251129
Clin Cancer Res. 2017 Aug 15;23(16):4617-4624
pubmed: 28428192
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1238-46
pubmed: 25808630
Appl Radiat Isot. 2019 Nov;153:108816
pubmed: 31344650
Nucl Med Biol. 1999 Jul;26(5):581-9
pubmed: 10473198
Curr Radiopharm. 2018;11(3):180-191
pubmed: 29766832
Neuroendocrinology. 2012;95(2):157-76
pubmed: 22262022
Inorg Chem. 2022 Aug 15;61(32):12847-12855
pubmed: 35914099
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988
pubmed: 29497803
Lancet Oncol. 2021 Dec;22(12):1752-1763
pubmed: 34793718
J Am Chem Soc. 2021 Jul 14;143(27):10429-10440
pubmed: 34190542
Neuroendocrinology. 2016;103(2):172-85
pubmed: 26731013
Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S103-12
pubmed: 22388631
Inorg Chem. 2020 Sep 8;59(17):12156-12165
pubmed: 32677829
Neuroendocrinology. 2004;80 Suppl 1:3-7
pubmed: 15477707
Clin Nucl Med. 2020 Mar;45(3):241-243
pubmed: 31977472
Eur J Nucl Med. 2001 Sep;28(9):1319-25
pubmed: 11585290
J Pediatr Hematol Oncol. 2016 Mar;38(2):87-96
pubmed: 26296147
EJNMMI Res. 2016 Dec;6(1):83
pubmed: 27873240
Int J Cancer. 1997 Mar 4;70(5):530-7
pubmed: 9052751
J Nucl Med. 2017 Oct;58(10):1624-1631
pubmed: 28408529
Eur J Nucl Med. 2001 Jul;28(7):836-46
pubmed: 11504080
Pharmaceutics. 2021 Oct 16;13(10):
pubmed: 34683999
J Nucl Med. 2012 Dec;53(12):1951-9
pubmed: 23139086
EJNMMI Radiopharm Chem. 2022 Sep 6;7(1):23
pubmed: 36068452
ACS Omega. 2020 Oct 06;5(41):26431-26440
pubmed: 33110971
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):129-138
pubmed: 30232539
BMC Cancer. 2019 Aug 8;19(1):788
pubmed: 31395036
Semin Nucl Med. 2006 Apr;36(2):147-56
pubmed: 16517236
J Nucl Med. 2021 Jul 1;62(7):1012-1015
pubmed: 33127622
J Nucl Med. 2023 Feb;64(2):219-220
pubmed: 36265909
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):728-742
pubmed: 30506283
Neuroendocrinology. 2021;111(4):330-343
pubmed: 32097917
Anal Chem. 2005 Oct 1;77(19):6288-91
pubmed: 16194090
J Nucl Med. 2014 Feb;55(2):183-90
pubmed: 24434296
Bioconjug Chem. 2000 Jul-Aug;11(4):510-9
pubmed: 10898572
EJNMMI Radiopharm Chem. 2021 Dec 20;6(1):38
pubmed: 34928478
Indian J Nucl Med. 2020 Jul-Sep;35(3):226-228
pubmed: 33082679
Cancer Biother Radiopharm. 2018 Oct;33(8):336-348
pubmed: 29889562
Pharmaceutics. 2021 Sep 13;13(9):
pubmed: 34575538
Crit Rev Oncol Hematol. 2018 Mar;123:7-20
pubmed: 29482781
Nucleosides Nucleotides Nucleic Acids. 2020;39(1-3):439-452
pubmed: 31560250
Curr Radiopharm. 2018;11(3):156-172
pubmed: 29658444
J Nucl Med. 2023 Apr;64(4):549-554
pubmed: 36396453
Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1207-1214
pubmed: 28246882
Semin Nucl Med. 2019 Sep;49(5):422-437
pubmed: 31470935
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):54-63
pubmed: 34448031
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Nature. 1979 Aug 9;280(5722):512-4
pubmed: 460433
EJNMMI Phys. 2021 Jan 12;8(1):4
pubmed: 33432383
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):704-717
pubmed: 30267116
J Nucl Med. 2011 Dec;52 Suppl 2:56S-63S
pubmed: 22144556
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):279-289
pubmed: 34196752
Theranostics. 2016 Feb 13;6(4):501-10
pubmed: 26941843
Curr Radiopharm. 2018;11(3):173-179
pubmed: 29669509
Proc Natl Acad Sci U S A. 1982 Aug;79(15):4575-9
pubmed: 6126875
Cancer Biother Radiopharm. 2002 Apr;17(2):219-31
pubmed: 12030116
Clin Cancer Res. 2022 May 13;28(10):2030-2037
pubmed: 35247915
Semin Nucl Med. 2002 Apr;32(2):110-22
pubmed: 11965606
J Nucl Med. 2014 Sep;55(9):1492-8
pubmed: 24982438
Cancer Med. 2021 Feb;10(3):1128-1140
pubmed: 33347715
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):721-728
pubmed: 31758224
Clin Cancer Res. 2019 Jan 15;25(2):868-880
pubmed: 30352909
Endocr Relat Cancer. 2010 Jan 29;17(1):R75-90
pubmed: 20008097
Bioconjug Chem. 2022 Jun 15;33(6):1222-1231
pubmed: 35670495
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2711-2712
pubmed: 32123970
EJNMMI Res. 2016 Dec;6(1):6
pubmed: 26791386
Appl Radiat Isot. 2021 Jun;172:109676
pubmed: 33725503
J Nucl Med. 2022 Apr;63(4):584-590
pubmed: 34385334
Endocr Rev. 2003 Aug;24(4):389-427
pubmed: 12920149
Appl Radiat Isot. 2005 May;62(5):667-79
pubmed: 15763472
Endocr Rev. 2004 Jun;25(3):458-511
pubmed: 15180952
Chem Commun (Camb). 2018 Mar 8;54(21):2599-2602
pubmed: 29388990
Chemistry. 2020 Sep 4;26(50):11435-11440
pubmed: 32588455
AJR Am J Roentgenol. 2018 Aug;211(2):278-285
pubmed: 29949416
J Nucl Med. 2018 May;59(5):795-802
pubmed: 29326358
Phys Med Biol. 2011 Feb 7;56(3):721-33
pubmed: 21220845
Appl Radiat Isot. 2012 Nov;70(11):2602-7
pubmed: 22940414
PLoS One. 2014 Feb 07;9(2):e88239
pubmed: 24516620
Theranostics. 2020 May 25;10(15):6946-6958
pubmed: 32550914
Eur J Nucl Med. 2001 Oct;28(10):1552-4
pubmed: 11685499
Theranostics. 2020 Jul 23;10(20):9364-9377
pubmed: 32802197
J Nucl Med. 2022 Jul 21;:
pubmed: 35863893
Biochem Biophys Res Commun. 1980 Sep 30;96(2):725-34
pubmed: 6107078
Molecules. 2018 Mar 05;23(3):
pubmed: 29510568
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3596-3597
pubmed: 35522323
Bioconjug Chem. 2006 Nov-Dec;17(6):1551-60
pubmed: 17105236
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1441-8
pubmed: 20461371
Sci Rep. 2019 Aug 12;9(1):11671
pubmed: 31406320
Cancer. 2015 Feb 15;121(4):589-97
pubmed: 25312765
Cancers (Basel). 2020 Apr 21;12(4):
pubmed: 32326199
Cancers (Basel). 2021 Apr 20;13(8):
pubmed: 33923965
Theranostics. 2020 Sep 14;10(25):11359-11375
pubmed: 33052220
Inorg Chem. 2021 Mar 15;60(6):4076-4092
pubmed: 33635057
Indian J Nucl Med. 2021 Apr-Jun;36(2):114-119
pubmed: 34385780
Front Oncol. 2022 Feb 03;12:796657
pubmed: 35186737
J Nucl Med. 2016 Dec;57(12):1941-1944
pubmed: 27390158
Mol Imaging Radionucl Ther. 2022 Jun 27;31(2):139-141
pubmed: 35771003
JAMA Oncol. 2017 Oct 01;3(10):1335-1342
pubmed: 28448665
Eur J Nucl Med Mol Imaging. 2014 May;41(5):925-33
pubmed: 24504504
J Nucl Med. 2005 Jan;46 Suppl 1:83S-91S
pubmed: 15653656
Cancer Med. 2017 Nov;6(11):2745-2756
pubmed: 28980417
Phys Med Biol. 2017 Jun 7;62(11):4406-4420
pubmed: 28362640
Appl Radiat Isot. 2012 Nov;70(11):2590-5
pubmed: 22944532
Nature. 1981 Jul 2;292(5818):55-8
pubmed: 6116194
Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1845-51
pubmed: 24615468
J Med Chem. 2002 Jan 17;45(2):469-77
pubmed: 11784151
J Med Chem. 1999 Jul 29;42(15):2988-92
pubmed: 10425108
Inorg Chem. 2022 Jan 17;61(2):801-806
pubmed: 34965102
BMC Cancer. 2022 Dec 22;22(1):1346
pubmed: 36550428
Appl Radiat Isot. 2013 Jun;76:38-45
pubmed: 23084477
J Nucl Med. 2022 Feb;63(2):218-225
pubmed: 34049983
Neuroendocrinology. 2013;97(4):347-54
pubmed: 23392072
EJNMMI Radiopharm Chem. 2019 Aug 6;4(1):21
pubmed: 31659557
Ann Oncol. 1999;10 Suppl 2:S23-9
pubmed: 10399029
Clin Nucl Med. 2022 Feb 1;47(2):e156-e157
pubmed: 34284478
Appl Radiat Isot. 2016 Dec;118:366-374
pubmed: 27776333
J Am Chem Soc. 2019 Dec 11;141(49):19404-19414
pubmed: 31794205
Clin Nucl Med. 2022 Feb 1;47(2):e184-e186
pubmed: 34507333
Appl Radiat Isot. 2020 Oct;164:109262
pubmed: 32819503
Cancers (Basel). 2022 Sep 29;14(19):
pubmed: 36230691
Endocr Relat Cancer. 2016 Aug;23(8):587-94
pubmed: 27492634

Auteurs

Léa Rubira (L)

Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34090 Montpellier, France.

Emmanuel Deshayes (E)

Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34090 Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University Montpellier, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.

Lore Santoro (L)

Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34090 Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University Montpellier, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.

Pierre Olivier Kotzki (PO)

Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34090 Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University Montpellier, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.

Cyril Fersing (C)

Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34090 Montpellier, France.
IBMM, University Montpellier, CNRS, ENSCM, 34293 Montpellier, France.

Classifications MeSH